Clinical Trial Update: Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of carboplatin, paclitaxel, and bevacizumab in advanced endometrial cancer; the study status is completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Avastin (bevacizumab)
• CARBOPLATIN (Carboplatin)
• Taxol (paclitaxel)

Snippet

Sponsor: David O'Malley | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-03-28